| Bioactivity | α-Glucosidase-IN-31 (compound R1) is an orally active, potent α-Glucosidase inhibitor with an IC50 value of 10.1 μM. α-Glucosidase-IN-31 significantly reduces the blood glucose level and has antidiabetic activity[1]. |
| In Vivo | α-Glucosidase-IN-31 (compound R1; 10 mg/kg; 口服灌胃; 持续 15 天) 可显着降低糖尿病小鼠的血糖水平[1]。 |
| Name | α-Glucosidase-IN-31 |
| Formula | C18H18N4 |
| Molar Mass | 290.36 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ritu, et al. Design, synthesis and antidiabetic study of triazole clubbed indole derivatives as α-glucosidase inhibitors. Bioorg Chem. 2023 Oct;139:106750. |